Basic Plaquenil Information

• INN (International Nonproprietary Name): Hydroxychloroquine.
• Brand Names Available In United Kingdom: Plaquenil is marketed worldwide including the United Kingdom and is the most commonly dispensed brand for 200 mg film‑coated tablets; generic products labelled as Hydroxychloroquine Sulfate are also widely available.
• ATC Code: P01BA02.
• Forms & Dosages: Film‑coated tablet 200 mg commonly supplied in blister packs of 30 or 60 tablets; 100 mg tablets are rare and seen in some markets.
• Manufacturers In United Kingdom: Not specified.
• Registration Status In United Kingdom: Prescription (Rx) only and available in the UK market via national authorisations.
• OTC / Rx Classification: Prescription (Rx) only.

Key Findings From Recent Trials

Worried that hydroxychloroquine might be a hidden cure for COVID‑19 that your family missed out on?

Large randomised controlled trials and high‑quality pooled analyses through 2024 reported no consistent clinical benefit for hydroxychloroquine in COVID‑19.

The most robust hospital platform trials from the RECOVERY era and subsequent pooled work found no mortality or progression benefit for treating COVID‑19 with hydroxychloroquine.

Regulatory advice in the UK mirrored these findings and discouraged routine use for COVID‑19 outside clinical trials.

For licensed uses such as SLE and certain milder rheumatoid arthritis phenotypes, long‑term cohort studies and registries continue to show disease‑modifying benefits like fewer flares and reduced steroid need.

Safety signals in trials highlighted rare but serious cardiotoxicity such as QT prolongation and conduction block, especially when combined with other QT‑prolonging agents like azithromycin.

Long‑term observational data also confirmed cumulative‑dose related retinal toxicity risk, which is why ophthalmic monitoring remains standard practice.

In UK practice, Plaquenil is commonly dispensed as 200 mg film‑coated tablets and classified under ATC P01BA02, so dose and monitoring are essential to risk mitigation.

Main Outcomes

Are you asking what the bottom line of the studies is?

There was no reliable mortality or progression benefit for COVID‑19 in major RCTs.

SLE and milder RA cohorts show sustained clinical benefits including fewer flares and steroid‑sparing effects.

These autoimmune data underpin ongoing prescribing by rheumatologists and dermatologists.

Real‑world dispensing in the UK most commonly uses 200 mg tablets for chronic therapy and standard malaria doses for travel medicine.

Safety Observations

Concerned about side effects you might hear about online?

Trials and registries emphasise rare but potentially serious cardiac events related to QT prolongation and conduction disturbances.

Risk is amplified when hydroxychloroquine is co‑prescribed with QT‑prolonging drugs such as azithromycin or certain antipsychotics.

Long‑term use carries a cumulative retinal toxicity risk, particularly at higher doses, in the elderly and with longer duration of therapy.

Standard UK practice uses baseline and periodic ophthalmology checks to reduce the chance of permanent visual harm.

Clinical Mechanism Of Action

Want to know how hydroxychloroquine actually works in plain terms?

Hydroxychloroquine is a small‑molecule medicine that reduces inflammation by acting on immune cells and can make some intracellular parasites less viable.

Patients typically notice fewer autoimmune flares after several weeks of regular dosing.

Layman’s Explanation

How would a pharmacist explain it in the consultation room?

The drug gathers inside cell compartments called lysosomes and changes how immune cells process signals, which calms an overactive immune system in conditions such as SLE.

It also affects some malaria parasites by disrupting their ability to handle haem products, though resistance limits its use in some regions.

Scientific Breakdown

Would you like the technical version for clinicians?

Hydroxychloroquine accumulates in lysosomes and raises intralysosomal pH, disrupting antigen processing and presentation.

The drug interferes with Toll‑like receptor signalling in plasmacytoid dendritic cells, reducing type I interferon responses that are important in SLE pathogenesis.

It also modulates autophagy pathways and cytokine release including IL‑1 and IL‑6 production.

At higher concentrations, hydroxychloroquine blocks hERG and other cardiac ion channels, which explains QT prolongation and the small arrhythmic risk seen in trials.

Remember that therapeutic windows differ between short antimalarial regimens and long‑term autoimmune dosing, so monitoring is condition specific.

Scope Of Approved And Off‑Label Use

Are you wondering what conditions hydroxychloroquine is actually licensed for in the UK?

Hydroxychloroquine is authorised in the UK as a prescription medicine for the treatment and prevention of malaria where sensitivity permits and as a disease‑modifying antirheumatic drug for rheumatoid arthritis and systemic or discoid lupus.

Prescribers follow national guidance for indications, dosing and monitoring.

United Kingdom Approvals

Do UK clinicians still prescribe it for autoimmune disease?

Yes, rheumatologists routinely prescribe hydroxychloroquine for SLE and milder RA phenotypes because cohort and registry data support its disease‑modifying benefits.

Plaquenil 200 mg film‑coated tablets are commonly used in clinic and community settings.

Notable Off‑Label Trends

Has off‑label use changed since the pandemic?

High public interest produced spikes in off‑label prescribing for COVID‑19 early in the pandemic, but high‑quality evidence did not support routine use and UK guidance discouraged it outside trials.

Dermatology uses include cutaneous lupus and selected inflammatory dermatoses when other options are unsuitable.

Generic hydroxychloroquine sulfate availability and brand Plaquenil simplify access, though supply planning remains important in primary care and specialist clinics.

Dosage Strategy

Worried about getting the dose right for a family member?

Dosing must be tailored to the indication, bodyweight and organ function while aiming for the lowest effective chronic dose to reduce retinal risk.

General Dosing

What are the general rules for dosing hydroxychloroquine?

Autoimmune indications typically use lower once‑daily doses, whereas malaria prophylaxis and treatment use higher intermittent or short‑course regimens.

For chronic therapy, adults commonly take 200–400 mg daily, in a single dose or divided, with the aim to keep within recommended weight‑based limits.

Condition‑Specific Dosing

Which specific regimens are used for malaria and SLE?

Malaria prophylaxis commonly involves 400 mg weekly, started 1–2 weeks before travel and continued for 4 weeks after return.

Treatment regimens classically use an initial 800 mg followed by 400 mg at 6, 24 and 48 hours for a total around 2 g over three days, adjusted by weight for children.

Chronic RA and SLE dosing is usually 200–400 mg daily, with paediatric dosing weight‑based at about 3–7 mg/kg/day up to a 400 mg maximum.

Adjust doses carefully for elderly patients and those with renal or hepatic impairment, and ensure baseline ophthalmic screening before long‑term therapy.

Plaquenil 200 mg tablets are the most common dispensing form in the UK and should be taken exactly as prescribed.

Safety Protocols

Worried about long‑term risks when someone in your family starts hydroxychloroquine?

There are absolute contraindications and relative cautions that determine whether the medicine is suitable.

Contraindications

Which patients must not take hydroxychloroquine?

Do not prescribe for anyone with known hypersensitivity to hydroxychloroquine or other 4‑aminoquinolines.

Avoid in patients with pre‑existing retinopathy or recent maculopathy and in children under about six years for full‑strength tablets due to overdose risk.

Use caution and specialist input for patients with cardiac conduction disease, severe hepatic or renal impairment, G6PD deficiency, psoriasis, porphyria or in pregnancy and lactation unless benefits clearly outweigh risks.

Adverse Effects

What side effects do patients usually experience?

Common mild effects include nausea, abdominal discomfort, diarrhoea, headache and skin rash.

Long‑term therapy risks cumulative retinal toxicity that can cause visual changes, hence baseline and periodic ophthalmic screening are standard.

Serious but rare events include life‑threatening ventricular arrhythmias linked to QT prolongation, particularly when combined with other QT‑prolonging drugs.

Mitigation steps include baseline ECG if there is cardiac history or interacting medicines, a baseline eye check and scheduled ophthalmology reviews, renal and hepatic function monitoring, and patient education on urgent red flags.

Interaction Mapping

Worried that hydroxychloroquine might clash with other medicines you take?

Drug interactions can be important, especially for heart rhythm and blood sugar control.

Food Interactions

Do I need to stop eating certain foods while taking hydroxychloroquine?

There are no major food interactions that require avoidance, and taking the tablet with food often reduces stomach upset.

Theoretical effects from acid‑ or alkali‑altering agents on lysosomal pH do not usually require clinical action.

Drug Combinations To Avoid

Which medicines should be avoided or used with caution?

Avoid combining hydroxychloroquine with other QT‑prolonging agents such as azithromycin, certain antipsychotics and class IA or III antiarrhythmics unless ECG monitoring and specialist advice are in place.

Do not co‑prescribe other 4‑aminoquinolines like chloroquine because of additive toxicity.

Exercise caution with hypoglycaemic agents because hydroxychloroquine can potentiate antidiabetic effects and increase hypoglycaemia risk.

Although CYP450 interactions are limited, elderly patients with polypharmacy need a full medication review before starting therapy.

Patient Experience Analysis

Want to know what people who take hydroxychloroquine actually say?

Registry and survey data from rheumatology and lupus cohorts report many patients experiencing improved disease control and reduced steroid requirements on hydroxychloroquine.

Adherence is generally higher when patients recognise symptom improvement and when clinicians provide clear information and monitoring plans.

Survey Data

What do formal patient surveys show?

Patients commonly report reduction in flares and better long‑term disease control, with gastrointestinal upset and transient headaches cited among the common side effects.

Visual concerns are a leading reason for seeking ophthalmology review and sometimes prompt dose reassessment.

Forum Trends

Should you trust social media posts about Plaquenil shortages or miracle cures?

Post‑pandemic forums showed significant misinformation about COVID‑19 and hydroxychloroquine, and some patients reported anxiety about supply and safety.

In UK primary care, patients value the convenience of once‑daily dosing and the low cost of generic hydroxychloroquine, balanced against the need for regular eye tests.

Clear communication, printed or digital leaflets and shared care monitoring arrangements improve adherence and safety outcomes in routine practice.

Distribution And Pricing Landscape

Can I get Plaquenil quickly and affordably in the UK?

Plaquenil (Sanofi) and multiple generics are widely available in the United Kingdom, commonly in 200 mg blister packs of 30 or 60 tablets.

Generic manufacturing increased after pandemic supply strains, which helped stabilise availability from global suppliers.

Within the NHS context, per‑tablet cost is generally low due to generic competition, while community pharmacy dispensing margins and contract terms influence final private prescription charges.

Storage guidance for supply chains is room temperature 15–30°C and protection from moisture and freezing.

Note: in our online pharmacy, plaquenil is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Alternative Options

Worried about alternatives if hydroxychloroquine is unsuitable?

Several DMARDs and antimalarial options exist depending on the clinical need and risk profile.

Comparison Table

Which alternatives are commonly considered in clinic?

Methotrexate is a highly effective DMARD for RA but has different monitoring requirements including liver function and blood counts and is teratogenic.

Sulfasalazine is an option for seronegative arthritis with gastrointestinal side effects in some patients.

Leflunomide has potent activity but a long half‑life and requires cholestyramine washout if pregnancy is planned.

Biologic drugs such as TNF inhibitors are highly effective for RA but are expensive and require specialist initiation and infection screening.

Chloroquine is a related antimalarial with higher toxicity and more resistance concerns than hydroxychloroquine.

Pros And Cons

How does hydroxychloroquine stack up?

Pros include oral dosing, low cost for generics, steroid‑sparing effects and an established safety profile when monitoring is followed.

Cons include cumulative retinal risk, rare cardiotoxicity and lack of benefit for severe COVID‑19 as shown by RCTs.

Plaquenil 200 mg remains commonly used in the UK as a first‑line adjunct DMARD for appropriate patients.

Regulatory Status

Is hydroxychloroquine tightly regulated in the UK?

Hydroxychloroquine is prescription‑only across major jurisdictions and is authorised in the UK for malaria, RA and lupus indications via national regulatory pathways.

Safety advisories during and after the COVID‑19 period drew attention to QT risks and discouraged off‑label COVID use outside clinical trials.

Suspected adverse drug reactions such as cardiotoxicity and retinopathy should be reported to the MHRA Yellow Card scheme in the UK.

The ATC classification is P01BA02 and packaging commonly shows 200 mg film‑coated tablets in blister packs.

Consolidated FAQ

Looking for quick answers to the most common questions about plaquenil?

Is Plaquenil the same as hydroxychloroquine?

Yes, Plaquenil is the brand name for hydroxychloroquine 200 mg film‑coated tablets commonly used in the UK.

How long until it works for lupus or RA?

Clinical benefit often appears after four to twelve weeks of regular therapy.

Do I need eye tests?

Baseline ophthalmology assessment and periodic screening, usually annually after five years or sooner if risk factors exist, are standard practice.

Can it cause heart problems?

Rarely; QT prolongation and arrhythmia risk increase with other QT‑prolonging medicines and in patients with pre‑existing cardiac disease, so ECGs are advised when indicated.

Is it effective for COVID‑19?

High‑quality trials and regulatory guidance do not support routine use for COVID‑19 outside clinical trials.

What about overdose?

Seek immediate emergency care for suspected overdose; children are particularly vulnerable and symptoms can include vomiting, arrhythmias, seizures and collapse.

Visual Guide

What should clinicians show patients during counselling?

Provide a labelled image of the Plaquenil 200 mg film‑coated tablet and its blister packaging to avoid confusion with generics labelled Hydroxychloroquine Sulfate.

Include a dosing flowchart that separates malaria prophylaxis and treatment from chronic autoimmune regimens.

Show a monitoring timeline with baseline tests such as ECG and ophthalmology, then scheduled eye exams and renal/hepatic checks.

Infographic Content Suggestions

Which visual elements improve understanding and adherence?

Design an infographic with weight‑based dose adjustments, red flags for urgent review like visual change or palpitations, and a clear interaction checklist emphasising QT‑prolonging medicines to avoid.

Pair printed leaflets with NHS‑aligned information to support informed consent and shared care arrangements.

Storage And Transport

How should Plaquenil be handled in the pharmacy and at home?

Store hydroxychloroquine at room temperature between 15–30°C, protect it from moisture and light and do not freeze the product.

Keep tablets out of reach of children because accidental ingestion can be life‑threatening.

In community pharmacies maintain batch records, expiry monitoring and original packaging for clear labelling when dispensing.

For patient transport, ambient conditions are acceptable and blister packs help prevent dosing errors.

Patients should retain blister packs until finished and check for any tablet changes such as crumbling or colour change before use.

Guidelines For Proper Use

What should prescribers tick off before initiating hydroxychloroquine?

Confirm the indication, calculate a weight‑based dose where appropriate and check absolute contraindications such as retinopathy or hypersensitivity.

Arrange baseline investigations including renal and hepatic function and ensure a baseline ophthalmology referral.

Complete a drug interaction review, consider baseline ECG if there is cardiac history or interacting medicines, and document the monitoring schedule.

Prescriber Checklist

Which items are essential to document?

Record informed consent for long‑term therapy, schedule ophthalmology monitoring (usually annually after five years), and plan renal/hepatic checks.

Advise patients about missed dose policy — take as soon as remembered but do not double up — and give clear written instructions for red flags and emergency contact details.

Patient Counselling Points

What should patients be told to watch for?

Explain expected timeframe for benefit of several weeks, advise taking the tablet with food to reduce nausea, and stress the importance of routine eye tests.

Warn about palpitations, syncope or visual disturbances as red flags and recommend immediate medical review should these occur.

Inform patients about Yellow Card reporting for suspected adverse reactions and provide pharmacy contact details for supply questions.

Delivery Across United Kingdom